WHO Drug Information Vol. 15, No. 2, 2001
(2001; 91 pages)

Table of Contents

	Personal Perspectives
		Putting the “partnership” into public-private partnerships
		Drug studies in developing countries
	Reports on Individual Drugs
		Cannabinoids in the management of pain
		Treatment for tuberculosis and standard of care
	Vaccines and Biomedicines
		Group procurement of vaccines
		The GCC procurement system
		Evaluation of candidate HIV vaccines
		Diagnosis of prion diseases soon possible?
	Current Topics
		Implementation of the ICH common technical document
		Monitoring the emergence of antiretroviral resistance
		Pharmaceutical legislation review
		Argentina takes action against black market pharmaceuticals
		Pharmacopoeial quality of drugs supplied by Nigerian pharmacies
		Use of placebo in clinical trials
		WHO guidelines on good clinical practice reviewed
	General Information
		Harmonization and international drug monitoring
		International Federation of Associations of Pharmaceutical Physicians
	Regulatory and Safety Matters
		New Zealand and Australia: joint medicines regulatory body
		Bupropion safety information
		Bupropion update
		Itraconazole and congestive heart failure
		Terbinafine and hepatic failure
		Paediatric amiodarone labelling changes
		Cerivastatin: marketing discontinued
		Phenylpropanolamine withdrawn from market
		Counterfeit filgrastim
		Oxycodone: strengthened warning
		Nesiritide for heart failure
		Oprelvekin: paediatric safety information
		Peginterferon alfa-2b combined use: new labelling
		Ribavirin for combined use
		Sleep attacks with pramipexole and ropinirole
		Rosiglitazone-associated hepatic and cardiovascular events
		Clarithromycin: labelling change
		Herbal OTC remedy and hepatic dysfunction
		Antipsychotics and high prolactin
		Sildenafil: not for use with nitrates
		Propofol, heart failure and high dosages
		Bupropion and seizures
		Neurotoxicity with aciclovir and valaciclovir
		Revised labelling for levocarnitine
		Avoid trastuzumab and anthracyclines
	ATC/DDD Classification
		ATC/DDD Classification (final)
		ATC/DDD Classification (temporary)
	Essential Drugs
		Resurgence of sleeping sickness
	Recent Publications and Sources of Information
		GMP training modules
		Current challenges in pharmacovigilance
		WHO Reproductive Health Library
		Management of sexually transmitted infections
		Safe Blood Starts With Me
		Improved access to biomedical journals
		Global information flow
		First Asian course in problem-based pharmacotherapy teaching
	International Nonproprietary Names for Pharmaceutical Substances (INN)
	Dénominations communes internationales des Substances pharmaceutiques (DCI)
	Denominaciones Comunes Internacionales para las Sustancias Farmacéuticas (DCI)
	Amendments to previous lists/Modifications apportées aux listes antérieures/Modificaciones a las listas anteriores
	Annexes

WHO Drug Information Vol. 15, No. 2, 2001